June 18, 2012

Johnson & Johnson to Host Analyst Conference Call on Second-Quarter Results

NEW BRUNSWICK, N.J., June 18, 2012 /PRNewswire-FirstCall/ -- Johnson & Johnson (NYSE: JNJ) will host a conference call for investors at 8:30 a.m. (Eastern Time) on Tuesday, July 17th, to review second-quarter results.  Alex Gorsky, Chief Executive Officer, Dominic Caruso, Vice President, Finance and Chief Financial Officer, and Louise Mehrotra, Vice President, Investor Relations, will host the call.

Investors and other interested parties may access the conference call in the following ways:

At Johnson & Johnson's website: www.investor.jnj.com. This earnings webcast is optimized for mobile streaming on iOS devices such as iPhones, iPods, and iPads.  A webcast and podcast replay will be available approximately two hours after the conference call concludes.

By telephone: For both "listen-only" participants and those financial analysts who wish to take part in the question-and-answer portion of the call, the telephone dial-in number in the U.S. is 866-394-7609. For participants outside the U.S., the dial-in number is 706-643-8954. The conference ID number for all callers is 82061399.  A replay of the conference call will be available beginning at approximately 11:30 a.m. on July 17, 2012, and ending at 5:00 p.m. on July 24, 2012. The replay dial-in number for U.S. participants is 855-859-2056. For participants outside the U.S., the replay dial-in number is 404-537-3406. The replay conference ID number for all callers is 82061399.

About Johnson & Johnson
Caring for the world, one person at a time, inspires and unites the people of Johnson & Johnson. We embrace research and science - bringing innovative ideas, products and services to advance the health and well-being of people. Our approximately 129,000 employees at more than 250 Johnson & Johnson operating companies work with partners in health care to touch the lives of over a billion people every day, throughout the world.

 

SOURCE Johnson & Johnson

News Provided by Acquire Media


Close window | Back to top

Copyright 2014 Johnson & Johnson

This site is governed solely by applicable U.S laws and governmental regulations. Please see our Privacy Policy. Use of this site constitutes your consent to application of such laws and regulations and to our Privacy Policy.Your use of the information on this site is subject to the terms of our Legal Notice. You should view the News section and the most recent SEC Filings in the Investor section in order to receive the most current information made available by Johnson & Johnson.Contact Us with any questions or search this site for more information.